Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2022-10-07 Purchase |
2022-10-12 4:39 pm |
Inhibrx Inc. | INBX | VIKING GLOBAL INVESTORS LP Viking Global Opportunities Illiquid Investments Sub-Master LP Viking Global Opportunities Portfolio GP LLC Viking Global Opportunities GP LLC DRAGSA 50 LLC HALVORSEN OLE ANDREAS Ott David C. Shabet Rose Sharon 10% Owner |
1,333,333 | $30 | $39,999,857 | 4,211,892 (Indirect) |
View |
| 2022-10-04 Sale |
2022-10-05 4:15 pm |
Inhibrx Inc. | INBX | Eckelman Brendan P. Eckelman Living Trust Dated February 5 2014 Chief Scientific Officer |
40,000 | $27.82 | $1,112,813 | 2,555,553 (Indirect) |
View |
| 2022-09-06 Sale |
2022-09-07 4:57 pm |
Inhibrx Inc. | INBX | Eckelman Brendan P. Eckelman Living Trust Dated February 5 2014 Chief Scientific Officer |
40,000 | $14.91 | $596,274 | 2,595,553 (Indirect) |
View |
| 2022-08-02 Sale |
2022-08-04 4:33 pm |
Inhibrx Inc. | INBX | Eckelman Brendan P. Eckelman Living Trust Dated February 5 2014 Chief Scientific Officer |
40,000 | $18 | $719,835 | 2,635,553 (Indirect) |
View |
| 2022-07-07 Sale |
2022-07-08 4:03 pm |
Inhibrx Inc. | INBX | Eckelman Brendan P. Eckelman Living Trust Dated February 5 2014 Chief Scientific Officer |
40,000 | $17.17 | $686,800 | 2,675,553 (Indirect) |
View |
| 2022-04-05 Sale |
2022-04-07 4:11 pm |
Inhibrx Inc. | INBX | Eckelman Brendan P. Eckelman Living Trust Dated February 5 2014 Chief Scientific Officer |
400 | $25.04 | $10,016 | 2,715,553 (Indirect) |
View |
| 2021-03-24 Sale |
2021-03-24 7:12 pm |
Inhibrx Inc. | INBX | Eckelman Brendan P. Eckelman Living Trust Dated February 5 2014 Chief Scientific Officer |
17,000 | $19.02 | $323,340 | 2,715,953 (Indirect) |
View |
| 2021-02-16 Sale |
2021-02-18 5:08 pm |
Inhibrx Inc. | INBX | Eckelman Brendan P. Eckelman Living Trust Dated February 5 2014 Chief Scientific Officer |
17,000 | $25.9 | $440,300 | 2,732,953 (Indirect) |
View |
| 2021-02-16 Sale |
2021-02-18 5:06 pm |
Inhibrx Inc. | INBX | Wagner Klaus W. Chief Medical Officer |
176,033 | $24.43 | $4,300,095 | 215,150 (Direct) |
View |
| 2020-08-26 Purchase |
2020-08-28 4:29 pm |
Inhibrx Inc. | INBX | VIKING GLOBAL INVESTORS LP Viking Global Opportunities Illiquid Investments Sub-Master LP Viking Global Opportunities Portfolio GP LLC Viking Global Opportunities GP LLC DRAGSA 50 LLC HALVORSEN OLE ANDREAS Ott David C. Shabet Rose Sharon 10% Owner |
180,219 | $18.92 | $3,409,866 | 5,305,866 (Indirect) |
View |
| 2020-08-24 Purchase |
2020-08-25 7:47 pm |
Inhibrx Inc. | INBX | VIKING GLOBAL INVESTORS LP Viking Global Opportunities Illiquid Investments Sub-Master LP Viking Global Opportunities Portfolio GP LLC Viking Global Opportunities GP LLC DRAGSA 50 LLC HALVORSEN OLE ANDREAS Ott David C. Shabet Rose Sharon 10% Owner |
131,465 | $19.39 | $2,548,688 | 5,125,647 (Indirect) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2022-09-13 Gift |
2022-09-14 4:09 pm |
N/A N/A |
Inhibrx Inc. | INBX | Eckelman Brendan P. Eckelman Living Trust Dated February 5 2014 Chief Scientific Officer |
240,000 | $0 | 160,000 (Indirect) |
View |
| 2022-08-24 Gift |
2022-08-25 4:20 pm |
N/A N/A |
Inhibrx Inc. | INBX | Kayyem Jon Faiz Director |
11,900 | $0 | 3,312,301 (Indirect) |
View |
| 2022-08-05 Gift |
2022-08-08 4:22 pm |
N/A N/A |
Inhibrx Inc. | INBX | Kayyem Jon Faiz Director |
3,400 | $0 | 3,324,201 (Indirect) |
View |
| 2022-08-02 Gift |
2022-08-02 4:52 pm |
N/A N/A |
Inhibrx Inc. | INBX | Kayyem Jon Faiz Director |
143,500 | $0 | 25,000 (Indirect) |
View |
| 2022-05-25 Option Award |
2022-05-26 4:46 pm |
N/A 2032-05-25 |
Inhibrx Inc. | INBX | FORSYTH DOUGLAS Director |
15,000 | $0 | 47,259 (Direct) |
View |
| 2022-05-25 Option Award |
2022-05-26 4:38 pm |
N/A 2032-05-25 |
Inhibrx Inc. | INBX | Kayyem Jon Faiz Director |
15,000 | $0 | 47,259 (Direct) |
View |
| 2022-05-25 Option Award |
2022-05-26 4:34 pm |
N/A 2032-05-25 |
Inhibrx Inc. | INBX | Vuori Kristiina MD Director |
15,000 | $0 | 45,000 (Direct) |
View |
| 2022-05-25 Option Award |
2022-05-26 4:31 pm |
N/A 2032-05-25 |
Inhibrx Inc. | INBX | MANHARD KIMBERLY Director |
15,000 | $0 | 50,759 (Direct) |
View |
| 2022-01-11 Option Award |
2022-01-25 4:50 pm |
N/A 2032-01-11 |
Inhibrx Inc. | INBX | Deck Kelly Chief Financial Officer |
20,000 | $0 | 20,000 (Direct) |
View |
| 2021-12-07 Option Award |
2021-12-07 7:43 pm |
N/A 2031-12-07 |
Inhibrx Inc. | INBX | Vuori Kristiina MD Director |
30,000 | $0 | 30,000 (Direct) |
View |
| 2021-06-07 Option Award |
2021-06-08 5:22 pm |
N/A 2031-06-07 |
Inhibrx Inc. | INBX | FORSYTH DOUGLAS Director |
15,000 | $0 | 32,259 (Direct) |
View |
| 2021-06-07 Option Award |
2021-06-08 5:20 pm |
N/A 2031-06-07 |
Inhibrx Inc. | INBX | Kayyem Jon Faiz Director |
15,000 | $0 | 32,259 (Direct) |
View |
| 2021-06-07 Option Award |
2021-06-08 5:19 pm |
N/A 2031-06-07 |
Inhibrx Inc. | INBX | MANHARD KIMBERLY Director |
15,000 | $0 | 35,759 (Direct) |
View |
| 2021-01-15 Option Award |
2021-01-19 4:16 pm |
N/A 2021-01-15 |
Inhibrx Inc. | INBX | Eckelman Brendan P. Eckelman Living Trust Dated February 5 2014 Chief Scientific Officer |
40,000 | $0 | 120,000 (Direct) |
View |
| 2020-12-04 Gift |
2021-01-19 4:16 pm |
N/A N/A |
Inhibrx Inc. | INBX | Eckelman Brendan P. Eckelman Living Trust Dated February 5 2014 Chief Scientific Officer |
240,000 | $0 | 120,000 (Indirect) |
View |
| 2021-01-15 Option Award |
2021-01-19 4:14 pm |
N/A 2031-01-15 |
Inhibrx Inc. | INBX | Wagner Klaus W. Chief Medical Officer |
120,000 | $0 | 120,000 (Direct) |
View |
| 2021-01-15 Option Award |
2021-01-19 4:13 pm |
N/A 2031-01-15 |
Inhibrx Inc. | INBX | Deck Kelly Chief Financial Officer |
70,000 | $0 | 70,000 (Direct) |
View |
| 2021-01-15 Option Award |
2021-01-19 4:10 pm |
N/A 2031-01-15 |
Inhibrx Inc. | INBX | Lappe Mark Lappe Family Trust Chief Executive Officer |
145,000 | $0 | 704,462 (Direct) |
View |
| 2020-12-28 Gift |
2021-01-19 4:10 pm |
N/A N/A |
Inhibrx Inc. | INBX | Lappe Mark Lappe Family Trust Chief Executive Officer |
500,000 | $0 | 704,462 (Indirect) |
View |
Ownership |
2020-08-25 7:46 pm |
N/A N/A |
Inhibrx Inc. | INBX | VIKING GLOBAL INVESTORS LP Viking Global Opportunities Illiquid Investments Sub-Master LP Viking Global Opportunities Portfolio GP LLC Viking Global Opportunities GP LLC DRAGSA 50 LLC HALVORSEN OLE ANDREAS Ott David C. Shabet Rose Sharon 10% Owner |
0 | $0 | 4,994,182 (Indirect) |
View |
| 2020-08-21 Conversion |
2020-08-24 4:31 pm |
N/A N/A |
Inhibrx Inc. | INBX | RA CAPITAL MANAGEMENT L.P. Kolchinsky Peter Shah Rajeev M. 10% Owner |
5,829,637 | $0 | 2,129,003 (Indirect) |
View |
| 2020-08-21 Conversion |
2020-08-21 4:24 pm |
N/A N/A |
Inhibrx Inc. | INBX | FORSYTH DOUGLAS Director |
225,688 | $0 | 598,257 (Indirect) |
View |
| 2020-08-21 Option Award |
2020-08-21 4:24 pm |
N/A 2030-08-20 |
Inhibrx Inc. | INBX | MANHARD KIMBERLY Director |
17,259 | $0 | 17,259 (Direct) |
View |
Ownership |
2020-08-18 8:30 pm |
N/A N/A |
Inhibrx Inc. | INBX | RA CAPITAL MANAGEMENT L.P. Kolchinsky Peter Shah Rajeev M. 10% Owner |
0 | $0 | 2,129,003 (Indirect) |
View |
Ownership |
2020-08-18 7:27 pm |
N/A N/A |
Inhibrx Inc. | INBX | Lappe Mark Lappe Family Trust Chief Executive Officer 10% Owner |
0 | $0 | 3,149,714 (Indirect) |
View |
Ownership |
2020-08-18 7:27 pm |
N/A 2028-11-26 |
Inhibrx Inc. | INBX | Deck Kelly Chief Financial Officer |
0 | $0 | 115,061 (Direct) |
View |
Ownership |
2020-08-18 7:27 pm |
N/A N/A |
Inhibrx Inc. | INBX | Deveraux Quinn L. 10% Owner |
0 | $0 | 2,749,953 (Direct) |
View |
Ownership |
2020-08-18 7:26 pm |
N/A N/A |
Inhibrx Inc. | INBX | Wagner Klaus W. Chief Medical Officer |
0 | $0 | 503,367 (Direct) |
View |
Ownership |
2020-08-18 7:26 pm |
N/A N/A |
Inhibrx Inc. | INBX | FORSYTH DOUGLAS Director |
0 | $0 | 615,516 (Indirect) |
View |